Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 3—March 2019

Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015

Zimy WansaulaComments to Author , Jonathan M. WorthamComments to Author , Godwin Mindra, Maryam B. Haddad, Jorge L. Salinas, David Ashkin, Sapna B. Morris, Gail B. Grant, Smita Ghosh, and Adam J. Langer
Author affiliations: Centers for Disease Control and Prevention Atlanta, Georgia, USA (Z. Wansaula, J.M. Wortham, G. Mindra, M.B. Haddad, J.L. Salinas, S.B. Morris, G.B. Grant, S. Ghosh, A.J. Langer); Florida Department of Health, Tallahassee, Florida, USA (D. Ashkin)

Main Article

Table 2

Clinical characteristics, treatment duration, and outcomes of 13 male patients treated with BCG instillations for bladder cancer and subsequently reported to the National Tuberculosis Surveillance System, 2014–2015*

Patient Type of complication Time from BCG instillation into bladder to diagnosis Site of culture specimen Duration of treatment Outcome
1 Asymptomatic <6 mo Urine Not treated Alive
2 Cystitis <1 mo Urine Not treated Alive
3 Cystitis 4 mo Urine 3 weeks Alive
4 Epididymo-orchitis ND Abscess 9 mo Alive
5 Disseminated ND Urine 2 wks Died
6 Left hip involvement ND Abscess 1 mo Died
7 Parotiditis (case report C) ND Abscess 4 mo Died
8 Prosthetic joint infection (case report B) 9 mo Synovial fluid ND Alive
9 Prosthetic joint infection (case report D) 4 y Abscess 9 mo Alive
10 Septicemia 1 y Blood ND ND
11 Septicemia, military (case report A) <1 mo Blood 9 mo Alive
12 Spondylodiscitis ND Abscess 1 mo Died
Spondylodiscitis 10 y Abscess 1 mo Died

*BCG, Bacillus Calmette-Guérin; ND, not documented in the medical and public health records that were available during the case reviews.

Main Article

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.